Ingersoll Rand Other Non-Current Liabilities decreased by 7.5% to $427.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.9%, from $329.40M to $427.90M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 6.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $303.80M | $301.20M | $310.10M | $314.90M | $324.10M | $316.20M | $360.80M | $381.40M | $415.60M | $405.10M | $433.90M | $424.00M | $309.70M | $358.10M | $294.30M | $329.40M | $472.40M | $461.60M | $462.50M | $427.90M |
| QoQ Change | — | -0.9% | +3.0% | +1.5% | +2.9% | -2.4% | +14.1% | +5.7% | +9.0% | -2.5% | +7.1% | -2.3% | -27.0% | +15.6% | -17.8% | +11.9% | +43.4% | -2.3% | +0.2% | -7.5% |
| YoY Change | — | — | — | — | +6.7% | +5.0% | +16.3% | +21.1% | +28.2% | +28.1% | +20.3% | +11.2% | -25.5% | -11.6% | -32.2% | -22.3% | +52.5% | +28.9% | +57.2% | +29.9% |